American Conference Institute (ACI) will be holding is 13th Annual Summit on Biosimilars & Innovator Biologics: Legal, Regulatory, and Commercial Strategies for the Innovator and Biosimilars Marketplace on June 28-29, 2022 at the Hyatt Regency Boston. ACI faculty will offer presentations on the following topics: • Regulatory and Legislative Developments Impacting the Biopharmaceutical Industry • Satisfying Section 112 Requirements and the Future of Genus Claims • The "Skinny Label" Post-GSK v Tevaregarding Biosimilar Carve-Outs • Litigation Strategies for Challenging Reference Drug Patents in IPRs • The Role of ITC in Biotech Litigation • The Future of Patent Thicket on the…
